Search results
Federal report suggests ways to improve infant formula safety oversight
Deseret News via Yahoo News· 4 days agoThen the bacteria was found in the facility, though it was never found directly in baby formula and...
Transposons could be new targets for aging research and treatment
Medical Xpress· 1 day agoBenayoun, associate professor of gerontology, biological sciences, biochemistry and molecular medicine, said the COVID-19 pandemic was part of the inspiration for the study. While lockdowns ...
Third company recalls product over potential E.coli contamination
Press Association News via AOL· 1 day agoEarlier this month, the agency confirmed at least 37 people had been admitted to hospital following...
Kathleen Gallagher: We remain asleep at the wheel while coastal interests take our money, talent,...
Gannett via AOL· 4 days agoThis is the moment. Industrial robots, LiDAR, solar panels, genome sequencing and other “picks and shovels” for building deep tech companies are better and cheaper than a decade ago,
Illumina (ILMN) Advances in NGS With DRAGEN v4.3 Launch
Zacks via Yahoo Finance· 6 days agoClinical Labs' systematic research into the accuracy of variant calls made by DRAGEN v4.3 highlights...
Gene Editing Breakthrough: New Technique Boosts Crop Photosynthesis
SciTechDaily· 5 hours agoResearchers from the Innovative Genomics Institute at the University of California, Berkeley (UCB)...
Jumpcode Genomics and Takara Bio USA Announce Global Patent Partnership
Benzinga· 5 days agoCutting-edge technologies with potential to transform molecular biology Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, and Takara Bio USA, Inc.
Illumina (NASDAQ:ILMN) Shares Down 2.7% on Analyst Downgrade
ETF DAILY NEWS· 5 days agoIllumina, Inc. (NASDAQ:ILMN – Get Free Report) traded down 2.7% during trading on Wednesday after Evercore ISI lowered their price target on the stock from $195.00 to $175.00. Evercore ISI currently ...
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput...
Morningstar· 5 days agoVenlo, the Netherlands, and Redwood City, California, June 13, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the release of a new version of its clinical decision support software, QIAGEN Clinical Insight
Major food-maker recalls products over potential link to E.coli outbreak
Press Association News via AOL· 4 days agoEarlier this month, the agency confirmed at least 37 people had been admitted to hospital following...